Sohail, Amir H.
Afolaranmi, Oluwasegun
Wuraola, Funmilola Olanike
Caputo, Matthew
Gutierrez, George
Oyewole, Adewale
Ebekue, Dorcas O.
Adegbite, Zainab Oyindamola
Awe, Clement
Ogunniyi, Titilope
Opeyemi, Akinlusi
Nwankwo, Chinyere
Uwechue, Frances
Sherman, Dan
Lambert, Clara N.
Adedayo, Joseph
Diaz, Kristina
Christian, Elizabeth Nicole
Abdulkareem, Fatimah
Akin-Adigun, Olufemi
Akingbola, Adewunmi
Okeke, Sophia
Knapp, Gregory
Dare, Anna
Aduloju, Toluwanimi
Akinwumi, Moyinoluwa
Kohli-Lynch, Ciaran Navin
Chen, Ruohui
Nwogu, Chukwumere
Hirschhorn, Lisa R.
Adin-Cristian, Andrei
Iwuji, Chinenye
Ilegbune, Oge
Jimoh, Mutiu
Chugani, Bindiya
Oputa, Olise
Murthy, Shilpa
French, Dustin
Ackermann, Ron
Murphy, Robert
Seddoh, Anthony
Kingham, Peter
Alatise, Olusegun Isaac
Lumati, Juliet S.
Funding for this research was provided by:
Northwestern University
American Society of Clinical Oncology
Article History
Received: 8 October 2025
Accepted: 18 January 2026
First Online: 28 January 2026
Declarations
:
: The study team received approval for this trial from the IRBs at Northwestern University, University of Lagos, and Obafemi Awolowo Teaching Hospital Complex.
: Consent forms are available on request from the study principal investigators.
: The authors declare that they have no competing interests.